Tenaya Therapeutics, Inc.
Datakwaliteit: 83%
TNYA
NASDAQ
Manufacturing
Chemicals
€ 0,75
▲
€ 0,03
(4,85%)
6 months return
—
Momentum
Neutral
ROE
-99,18%
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-99,18%
Onder sectorgemiddelde (-54,49%)
ROIC-73,27%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio4,64
Interest CoverageN/A
Waardering
PE (TTM|NTM)
-1,77 | -1,53
Onder sectorgemiddelde (-1,50)
P/B Ratio1,94
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Negative free cash flow of -68,88 M
Price History
Financiële Trends
Koersdoel Analisten
7 analisten
Buy
+1100.0%
upside to target
Huidig
€ 0,75
Consensus Target
€ 9,00
€ 2,00
Laag
€ 40,00
Hoog
Vooruitzicht
Forward K/W
-1,53
Forward WPA
-€ 0,45
Omzet Sch.
0,0
Winstverassingen
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -€ 0,09
·
Rev Est: 7,50 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -€ 0,24 | -€ 0,14 | -€ 0,12 | -€ 0,12 | — | — |
| Estimate | -€ 0,21 | -€ 0,19 | -€ 0,15 | -€ 0,12 | -€ 0,09 | -€ 0,11 |
| Verrassing | -17,07% | +24,83% | +19,33% | +1,03% | — | — |
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: -99,18% · Net Margin: N/A
Profitability
ROE: -99,18% · Net Margin: N/A| Revenue (TTM) | N/A | Net Income (TTM) | -90,60 M |
| ROE | -99,18% | ROA | -79,78% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -68,88 M |
| ROIC | -73,27% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 4,64
Safety
D/E: N/A · Current: 4,64| Debt / Equity | N/A | Current Ratio | 4,64 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 48,03 M | Tangible Book Value | 82,87 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -1,77 · EV/EBITDA: N/A
Valuation
P/E: -1,77 · EV/EBITDA: N/A| P/E Ratio | -1,77 | Forward P/E | -1,53 |
| P/B Ratio | 1,94 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -42,86% | ||
| Market Cap | 160,71 M | Enterprise Value | 104,40 M |
Per Share
EPS: -0,59 · FCF/Share: -0,32
Per Share
EPS: -0,59 · FCF/Share: -0,32| EPS (Diluted TTM) | -0,59 | Revenue / Share | N/A |
| FCF / Share | -0,32 | OCF / Share | -0,31 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 76,03% · CapEx/Rev: N/A
Efficiency
FCF Conv: 76,03% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 76,03% |
| SBC-Adj. FCF | -83,09 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -90,60 M | -111,13 M | -124,08 M | -123,67 M | -72,72 M |
| EPS (Diluted) | -0,59 | -1,31 | -1,68 | -2,76 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -93,33 M | -115,95 M | -131,19 M | -125,62 M | -72,81 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 68,61 M | 86,74 M | 98,04 M | 94,54 M | 54,39 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 8,44 M | 8,47 M | 8,69 M | 6,47 M | 2,96 M |
| Interest Expense | — | — | — | — | — |
| Income Tax | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 146,92 M | 119,94 M | 170,52 M | 278,95 M | 314,19 M |
| Total Liabilities | 23,66 M | 27,09 M | 31,09 M | 35,57 M | 35,66 M |
| Shareholders' Equity | 123,27 M | 92,85 M | 139,42 M | 243,38 M | 278,53 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 100,55 M | 4,32 M | 45,68 M | 95,27 M | 38,13 M |
| Current Assets | 105,59 M | 67,38 M | 111,58 M | 193,75 M | 255,36 M |
| Current Liabilities | 15,44 M | 15,98 M | 22,73 M | 24,25 M | 21,77 M |
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers)
Vergeleken met vergelijkbare bedrijven in Manufacturing
Sectorvergelijking
vs Manufacturing sector mediaan (1605 peers) Vergeleken met vergelijkbare bedrijven in Manufacturing| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -1,8 | -1,5 |
| P/B | 1,9 | 1,6 |
| ROE % | -99,2 | -54,5 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
{"event":"ticker_viewed","properties":{"ticker":"TNYA","listing_kind":"stock","pathname":"/stocks/tnya","exchange":"NASDAQ","country":"US"}}